Liabilities / Assets
52nd percentile
Higher debt load relative to assets than 52% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.31x
Liabilities / Revenue
57th percentile
Higher debt load relative to revenue than 57% of similar nonprofits.
Net Margin
58th percentile
Higher net margin than 58% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
83rd percentile
Faster asset growth than 83% of similar nonprofits.
Revenue Growth
25th percentile
Faster revenue growth than 25% of similar nonprofits.
Balance Sheet
Assets
Up$446,188,087
Up $56,726,422 (+15%) from 2022
Net Assets
Up$307,180,230
Up $12,269,992 (+4.2%) from 2022
Liabilities
Up$139,007,857
Up $44,456,430 (+47%) from 2022
Revenue And Expenses
Revenue
Down$223,798,085
Down $14,797,420 (-6.2%) from 2022
Expenses
Up$215,759,942
Up $52,870,743 (+32%) from 2022
Net Income
Down$8,038,143
Down $67,668,163 (-89%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2022 to Jun 30, 2023
Mission and Program Overview
Mission
Breakthrough t1d is the leading global t1d organization working to accelerate life-changing breakthroughs to cure, prevent, and treat t1d and its complications.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $446,188,087
- Liabilities
- $139,007,857
- Net assets
- $307,180,230
- Revenue
- $223,798,085
- Expenses
- $215,759,942
- Net income
- $8,038,143